The management of patients with primary Sjogren syndrome (pSS) has long suffered from
the lack of effective treatments. Progress made in the understanding of pSS pathogenesis …

Primary Sjögren's syndrome is a systemic autoimmune disease characterized by
progressive exocrine gland destruction, resulting clinically in eyes and mouth dryness. To …

Sjögren's syndrome (SS) is a systemic autoimmune disease that mainly affects the exocrine
glands and usually presents as persistent dryness of the mouth and eyes. SS primarily …

Sjögren's syndrome (SS) is a systemic autoimmune disease that affects the exocrine glands,
mainly the salivary and lachrymal glands, with consequent persistent dryness of the mouth …

To date, no immunomodulatory drug has proved efficacious in primary Sjögren's syndrome
(pSS). In pSS, difficulties in drug efficacy assessment is related to the large spectrum of …

Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease characterized by
dryness and systemic involvement in more than a third of the patients. Patient management …

The use of biologic disease modifying antirheumatic drugs (bDMARDs) in systemic
autoimmune diseases such as rheumatoid arthritis and at a lesser extent in lupus, has been …

Importance of the field: Sjögren's syndrome (SS) is an autoimmune epithelitis. This
exocrinopathy is frequently associated with extraglandular complications, and the patients …

SS is a chronic systemic autoimmune disease characterized by decreased exocrine gland
function. A variety of other disease manifestations may also be present, including general …

SS is a chronic, autoimmune condition characterized by lymphocytic infiltration of the
exocrine glands and B-cell dysfunction. Current treatment strategies are largely empirical …